









Markets
/
Stocks
/
nasdaq-lmat
/

LeMaitre Vascular Inc

LMAT

92.370USD

+0.080+0.09%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

2.09BMarket Cap

44.38P/E TTM



LeMaitre Vascular Inc

92.370

+0.080+0.09%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-15

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

8 / 207

Overall Ranking

88 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 11 analysts

Buy

Current Rating

104.778

Target Price

+13.53%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 36.01% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 113.40.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.

Undervalued

The company’s latest PE is 44.20, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 23.37M shares, decreasing 3.01% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.60M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.42.

Financial Health

Currency: USD Updated：2025-09-15

The company's current financial score is 7.38, which is higher than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 59.87M, representing a year-over-year increase of 11.95%, while its net profit experienced a year-over-year increase of 11.37%.

Score

Industry at a Glance

Previous score

7.38

Change

2.01



Financials

8.57

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.83

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.55

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-15

The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 45.78, which is 12.57% below the recent high of 51.54 and 0.57% above the recent low of 45.52.

Score

Industry at a Glance

Previous score

3.11

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 8/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-15

The company’s current earnings forecast score is 7.27, which is lower than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for LeMaitre Vascular Inc is 106.00, with a high of 120.00 and a low of 92.00.

Score

Industry at a Glance

Previous score

7.64

Change

Support & Resistance

No Data

Analyst Rating

Based on 11 analysts

Buy

Current Rating

104.778

Target Price

+13.53%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

LeMaitre Vascular Inc

LMAT

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-15

The company’s current price momentum score is 9.36, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 104.76 and the support level at 82.80, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.91

Change

0.1

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.793

Neutral

RSI(14)

46.625

Neutral

STOCH(KDJ)(9,3,3)

24.986

Sell

ATR(14)

3.080

Low Volatility

CCI(14)

-118.002

Sell

Williams %R

67.780

Sell

TRIX(12,20)

0.191

Sell

StochRSI(14)

2.408

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

93.430

Sell

MA10

94.837

Sell

MA20

95.571

Sell

MA50

89.629

Buy

MA100

86.657

Buy

MA200

89.765

Buy

Institutional Confidence

Currency: USD Updated：2025-09-15

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 103.27%, representing a quarter-over-quarter decrease of 1.50%. The largest institutional shareholder is The Vanguard, holding a total of 1.60M shares, representing 7.06% of shares outstanding, with 0.70% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

3.12M

-4.67%

LeMaitre (George W)

1.83M

-3.45%

Conestoga Capital Advisors, LLC

1.64M

-3.05%

The Vanguard Group, Inc.

Star Investors

1.58M

+0.06%

Copeland Capital Management, LLC

1.08M

-7.96%

Geneva Capital Management LLC

863.75K

-0.21%

State Street Global Advisors (US)

810.24K

-3.97%

Congress Asset Management Company, LLP

644.41K

-10.79%

First Trust Advisors L.P.

400.75K

+737.96%

Geode Capital Management, L.L.C.

504.76K

-8.27%

Risk Assessment

Currency: USD Updated：2025-09-15

The company's beta value is 0.77. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.